Clinical trials
Chronic Limb-Threatening Ischemia trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2007 | 1 |
| 2009 | 4 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Unknown status | 6 |
| Recruiting | 4 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ospedale San Donato | 3 |
| IRCCS Multimedica | 2 |
| Maria Cecilia Hospital | 2 |
| AnGes USA, Inc. | 1 |
| Azienda Ospedaliera Universitaria Senese | 1 |
| Biotyx Medical (Shenzhen) Co., Ltd. | 1 |
| C. R. Bard | 1 |
| Carelon Research | 1 |
| Cook Group Incorporated | 1 |
| Federico II University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chronic Limb-Threatening Ischemia | 24 |
| Peripheral Arterial Disease | 8 |
| Diabetes Mellitus | 4 |
| Intermittent Claudication | 3 |
| Diabetic Foot | 2 |
| Thromboangiitis Obliterans | 2 |
| Acute Coronary Syndrome | 1 |
| Arterial Occlusive Diseases | 1 |
| Constriction, Pathologic | 1 |
| Gangrene | 1 |
Trials
Showing 26 to 24 of 24. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.